PD-1は,皮膚新抗原に対するCD8T細胞の耐性を維持する
Martina Damo1, Noah I Hornick1,2, Aarthi Venkat3
1Department of Immunobiology, Yale University School of Medicine, New Haven, CT, USA.
Nature
|June 21, 2023
まとめ
プログラム細胞死タンパク質1 (PD-1) は,自己反応性CD8T細胞を調節することによって皮膚の耐性を維持する. これは組織損傷と免疫関連の有害事象を防止し,外周T細胞耐性の新しいモデルをサポートします.
科学分野:
- 免疫学
- 細胞生物学
- 皮膚科
背景:
- 健康な個体には自己反応性T細胞があり,周辺の耐性メカニズムが必要である.
- PD-1のようなチェックポイント受容体は,自己反応性T細胞の消去または無能化によって耐性を誘発すると考えられています.
- チェックポイント阻害剤で治療されたがん患者の免疫関連の有害事象は,既存の耐性モデルに異議を唱える.
研究 の 目的:
- 皮膚特異抗原モデルの周辺耐性を維持するPD-1の役割を調査する.
- PD-1が組織内のエフェクタ CD8 T細胞を調節するメカニズムを解明する.
- 免疫関連の有害事象に対するこれらの発見の関連性を調べる.
主な方法:
- 皮膚特異のT細胞抗原発現を持つマウスモデルの開発.
- 皮膚におけるCD8T細胞の浸透,分化,機能の分析
- 免疫関連の有害事象を有する患者の皮膚バイオプシのトランスクリプトミックの分析
主要な成果:
- PD-1は,組織に浸透する抗原特異性CD8T細胞が完全に病原性になるのを防ぐ.
- PD-1は,効果分子分泌と,CD8T細胞による抗原発現細胞へのアクセスを制限する.
- PD- 1の欠如は,CD8 T細胞媒介による表皮細胞の除去と局所的な病変を引き起こす.
- 皮膚リケノイド免疫関連不良症状の患者で,クローン的に拡張したエフェクターCD8T細胞が見つかりました.
結論:
- PD-1は,エフェクタ CD8 T細胞を調節することにより,皮膚の耐性を維持するために不可欠です.
- PD-1は,免疫病変を引き起こすことなく,エフェクターT細胞と抗原発現細胞の共存を可能にします.
- これらの発見は,PD-1の組織特異的な調節機能を含む周辺T細胞耐性の改訂モデルを支持する.
関連する概念動画
T Cell Activation and Clonal Selection
837
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
837
Special Features of Adaptive Immunity
907
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
907
Cytotoxic T Cells-mediated Immune Response
998
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
998
Cell-mediated Immune Responses
69.1K
Overview
69.1K
Antigens Involved in Adaptive Immunity
563
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
563


